Sector
PharmaceuticalsOpen
₹174.9Prev. Close
₹169.95Turnover(Lac.)
₹10.75Day's High
₹177.9Day's Low
₹167.1552 Week's High
₹232.952 Week's Low
₹86.65Book Value
₹57.91Face Value
₹10Mkt Cap (₹ Cr.)
236.04P/E
21.14EPS
8.04Divi. Yield
1.1817 Jul 2023
12:00 AM
BookCloser
17 Jul 2023
12:00 AM
AGM
Announcement Date: 17 Jul, 2023
30 May 2023
12:00 AM
Dividend
Dividend Amount: 2
13 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 13.88 | 13.88 | 13.88 | 13.88 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 58.39 | 52.57 | 47.63 | 45.21 |
Net Worth | 72.27 | 66.45 | 61.51 | 59.09 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 109.31 | 136.14 | 107.22 | 113.36 |
yoy growth (%) | -19.7 | 26.97 | -5.41 | 13.76 |
Raw materials | -55.43 | -61.56 | -49.47 | -53.93 |
As % of sales | 50.7 | 45.22 | 46.13 | 47.57 |
Employee costs | -10.58 | -12.2 | -9.46 | -12.56 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 3.08 | 5.72 | 2.03 | 1.96 |
Depreciation | -5.95 | -6.66 | -5.92 | -6.77 |
Tax paid | -0.82 | -1.51 | 0.1 | -0.72 |
Working capital | 1.54 | -1.82 | 5.34 | 11.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.7 | 26.97 | -5.41 | 13.76 |
Op profit growth | -31.64 | 24.51 | -13.28 | 63.81 |
EBIT growth | -46.15 | 29.53 | -14.37 | 134.25 |
Net profit growth | -46.26 | 96.56 | 73.22 | -127.82 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Dinesh B Patel
ED / MD / Promoter
Himanshu C Patel
Independent Non Exe. Director
Gaurang Dalal
Non Executive Director
Anar H Patel
Independent Non Exe. Director
Gauri Trivedi
Independent Non Exe. Director
Hemendrakumar C Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Denis Chem Lab Ltd
Summary
Denis Chem Lab Ltd, was incorporated in 1980 and was converted into a Public Limited Company in 1982. The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology.The Company is a manufacturer of antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti anaerobic injections, irrigation solutions etc. It is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms. These products are filled in glass bottles in volume of 100 ml, 250 ml, 500 ml and 1000 ml. in aseptic condition and followed by terminal sterilization. The Company introduced I.V. Fluids facility in plastic bottles using Blow Fill Seal (BFS) technology, which commissioned in 2007-08. It started manufacturing of I.V. Fluids in P.P. Plastic bottles using latest BFS technology with an installed capacity of 15 million units per annum in 2016.In 2018-19, the Company implemented a project with the addition of 100 ml Eurohead products to its Aquapulse B
Read More
What is the Denis Chem Lab Ltd share price today?
The Denis Chem Lab Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹170.1 today.
What is the Market Cap of Denis Chem Lab Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Denis Chem Lab Ltd is ₹236.04 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Denis Chem Lab Ltd?
The PE and PB ratios of Denis Chem Lab Ltd is 21.14 and 2.93 as of 22 Jul ‘24
What is the 52 Week High and Low of Denis Chem Lab Ltd?
The 52-week high/low is the highest and lowest price at which a Denis Chem Lab Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Denis Chem Lab Ltd is ₹86.65 and ₹232.9 as of 22 Jul ‘24
What is the CAGR of Denis Chem Lab Ltd?
Denis Chem Lab Ltd's CAGR for 5 Years at 37.01%, 3 Years at 48.26%, 1 Year at 93.04%, 6 Month at 29.09%, 3 Month at 13.26% and 1 Month at -17.02%.
What is the shareholding pattern of Denis Chem Lab Ltd?
The shareholding pattern of Denis Chem Lab Ltd is as follows:
Promoters - 38.98 %
Institutions - 0.00 %
Public - 61.02 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
